To include your compound in the COVID-19 Resource Center, submit it here.

Diabetes hits a checkpoint

Cranking up PD-L1 on HSPCs for autoimmune disease

A Science Translational Medicine study suggests increasing PD-L1 levels in hematopoietic stem and progenitor cells (HSPCs) could help treat Type I diabetes. Additionally, the authors think transplants of HSPCs modified with PD-L1-boosting gene therapies or compounds could be deployed to treat a wide range of autoimmune diseases, and the

Read the full 493 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE